Recombinant Human Vesicle-trafficking protein SEC22a (SEC22A)

What is SEC22A and what is its primary cellular function?

SEC22A (SEC22 homolog A, vesicle trafficking protein) is a member of the SEC22 family of proteins that functions primarily in vesicle transport between the endoplasmic reticulum (ER) and the Golgi complex. It belongs to the synaptobrevin family and plays a crucial role in intracellular membrane trafficking pathways .

The protein is characterized by:

• Gene ID: 26984 (human)

• Molecular weight: Approximately 34.8 kDa

• Cellular localization: Primarily associated with membranes of the ER, Golgi, and transport vesicles

Research methodologies for studying its function include localization studies with fluorescently tagged constructs, interaction assays, and functional disruption through genetic methods. When studying SEC22A, researchers should consider its role within the broader context of the vesicular transport machinery rather than as an isolated protein.

How does SEC22A differ from other SEC22 family members?

SEC22A is one of several SEC22 family members, which also include SEC22B (also known as ERS-24). While they share structural similarities, they exhibit distinct cellular functions and expression patterns:

Research indicates that while SEC22B has been more extensively studied and has established roles in conventional ER-Golgi transport, SEC22A may have more specialized functions. To distinguish between them in experimental contexts, researchers should use highly specific antibodies or tagged constructs and validate with knockout controls .

What are the optimal expression systems for producing recombinant SEC22A protein?

Producing high-quality recombinant SEC22A requires careful consideration of expression systems. Based on research findings:

For HEK293T expression, evidence suggests using:

• C-Myc/DDK tags for purification and detection

• Purification yields of >50 μg/mL as determined by microplate BCA method

• Purity >80% as determined by SDS-PAGE and Coomassie blue staining

What methodologies are effective for studying SEC22A localization and trafficking dynamics?

Visualizing SEC22A localization and tracking its movement through cellular compartments requires specialized techniques:

• Fluorescent protein fusion constructs:

  • mCherry::SEC22 or EGFP::SEC22 fusions allow live-cell imaging of protein dynamics

  • Both N-terminal and C-terminal tagging approaches have been successful, though C-terminal tagging may interfere less with protein function

• Immunofluorescence microscopy:

  • Fixed-cell imaging using specific anti-SEC22A antibodies

  • Co-staining with markers for cellular compartments (RAB7 for late endosomes, LMP-1 for lysosomes)

• Live-cell dynamics:

  • FRAP (Fluorescence Recovery After Photobleaching) to measure mobility

  • Photoactivatable GFP fusions to track movement from specific compartments

Research has shown that SEC22 proteins localize primarily to cytoplasmic dots representing transport vesicles, with strong fluorescence in developing structures. When designing localization experiments, researchers should include appropriate controls and co-localization markers to definitively identify the subcellular compartments .

How does SEC22A influence late endosome/multivesicular body (MVB) function and RNA interference pathways?

Recent research has uncovered an unexpected role for SEC22 in RNA interference pathways, mediated through its effects on late endosomes/multivesicular bodies:

Studies in C. elegans demonstrated that:

• Loss of SEC-22 results in enhanced RNAi efficiency upon ingestion of double-stranded RNA

• Overexpression of SEC-22 inhibits RNAi in wild-type animals

• SEC-22 primarily affects RNA import or cell-autonomous RNAi in target cells

• mCherry::SEC-22 localizes to late endosomes/MVBs, which are enlarged in sec-22 mutants

Mechanistically, SEC-22 appears to reduce RNAi efficiency potentially by:

• Promoting fusion between late endosomes/MVBs and lysosomes

• Interacting with late endosome-associated RNA transport protein SID-5

• Affecting the stability or trafficking of RNAi machinery components

For researchers investigating SEC22A's role in RNAi pathways, both loss-of-function and gain-of-function approaches should be employed, with careful attention to tissue-specific effects. Expression of SEC-22 from different tissue-specific promoters can help determine where it primarily functions in the RNAi pathway .

What protein-protein interactions are crucial for SEC22A function, and how can they be studied?

SEC22A functions through interactions with various proteins in the vesicular trafficking machinery. Key interactions and methods to study them include:

When studying these interactions, researchers should consider:

• The transmembrane nature of SEC22A can make co-immunoprecipitation challenging

• Yeast two-hybrid systems may require modification for membrane proteins

• Proximity-based methods like BioID or APEX may be more effective for detecting transient interactions

• In vitro reconstitution of membrane systems may be necessary to study SNARE complex formation

Research has shown that these interactions are often dynamic and regulated by cellular conditions, so experimental design should account for this temporal and spatial regulation .

How can researchers resolve contradictory findings regarding SEC22A localization and function?

Contradictory findings in SEC22A research can arise from several sources:

• Cell type-specific differences:

  • SEC22A may have distinct localizations and functions in different cell types

  • Resolution approach: Clearly document cell types used and perform comparative studies across multiple cell lines

• Tag interference:

  • Different tags (GFP, mCherry, FLAG, etc.) may affect protein localization or function

  • Resolution approach: Compare N- and C-terminal tags, use small epitope tags, and validate with untagged protein

• Expression level artifacts:

  • Overexpression can lead to mislocalization and artificial interactions

  • Resolution approach: Use endogenous tagging approaches (CRISPR/Cas9) or tetracycline-inducible systems for controlled expression

• Antibody specificity issues:

  • Cross-reactivity with other SEC22 family members

  • Resolution approach: Validate antibodies using knockout controls, use multiple antibodies targeting different epitopes

Research has demonstrated that SEC22 proteins can show different localization patterns depending on expression levels. For example, studies found that SEC22 expression under its own promoter versus overexpression from a constitutive promoter can lead to different phenotypic outcomes in complementation assays .

What are the critical controls for functional studies involving SEC22A knockout or knockdown?

When designing functional studies involving SEC22A disruption, the following controls are essential:

• Rescue experiments:

  • Reintroduction of wild-type SEC22A should restore normal phenotype

  • Use both native promoter and overexpression constructs to assess dose-dependent effects

  • Example: In sec-22 mutant studies, expressing SEC22 under its own promoter restored normal ascospore pigmentation and germination, while overexpression showed partial complementation

• Assessment of compensatory mechanisms:

  • Measure expression of other SEC22 family members (SEC22B, SEC22C)

  • Evaluate changes in functionally related proteins

  • Research shows potential compensation by other vesicular trafficking components

• Validation of knockout/knockdown efficiency:

  • Confirm at both mRNA (RT-qPCR) and protein (Western blot) levels

  • Use multiple siRNAs/shRNAs targeting different regions to rule out off-target effects

• Phenotypic controls:

  • Compare with knockouts/knockdowns of known interaction partners

  • Include conditions that bypass the pathway involving SEC22A

For phenotypic analyses, researchers should examine multiple parameters including growth rate, vesicular morphology, protein trafficking efficiency, and specific pathway functions like RNAi efficiency. Studies have shown that SEC22 disruption can lead to enlarged late endosomes/MVBs, suggesting a role in maintaining proper vesicle morphology and function .

How is SEC22A implicated in disease mechanisms, and what research approaches can elucidate these connections?

While direct links between SEC22A and human diseases are still emerging, vesicular trafficking defects are implicated in numerous pathologies. Research approaches to investigate SEC22A in disease contexts include:

• Gene expression analysis in disease tissues:

  • Multiple studies have documented altered SEC22A expression in response to various chemical exposures and disease states

  • In rats, SEC22A expression changes have been documented in response to treatments with compounds like epigallocatechin gallate, dimethylhydrazine, and estradiol

• Genetic association studies:

  • Analysis of SEC22A variants in patient cohorts

  • Evaluation of SEC22A expression in disease-relevant tissues

• Functional modeling:

  • Use of patient-derived cells to assess SEC22A localization and function

  • CRISPR/Cas9-mediated introduction of disease-associated variants

• Pathway analysis:

  • Assessment of SEC22A's role in disease-relevant trafficking pathways

  • Investigation of interactions with known disease-associated proteins

Research indicates that SEC22 proteins' involvement in fundamental cellular processes like vesicular trafficking and potentially RNA interference may have implications for various diseases. The experimental approaches should be tailored to the specific disease context and potential mechanisms involving SEC22A .

What considerations should be made when interpreting SEC22A phenotypes across different model organisms?

Comparative studies of SEC22A across species reveal both conserved and divergent functions:

When interpreting phenotypes across species, researchers should consider:

• Evolutionary conservation:

  • Core functions in vesicular trafficking are likely conserved

  • Species-specific adaptations may exist for specialized functions

• Genetic redundancy:

  • Different organisms may have varying numbers of SEC22 paralogs

  • Compensation mechanisms may differ across species

• Experimental context:

  • Growth conditions and experimental setups should be optimized for each model

  • Phenotypic readouts may require different techniques in different organisms

Studies in C. elegans revealed an unexpected role for SEC-22 in RNAi efficiency, while work in fungi demonstrated its importance in development. These diverse findings suggest that while the core function in vesicular trafficking is conserved, SEC22 proteins may have acquired additional roles during evolution that should be considered when translating findings across species .